
Boric Acid (99.9% Granular) - Peru CAS: 10043-35-3

War-risk insurance premiums surged by around 50% during the earlier Gulf disruption, increasing logistics costs for chemical shipments. Procurement and compliance teams should understand how insurance pricing and regulatory oversight can influence sourcing decisions and freight budgets.

ECHA's upcoming SVHC candidate list update could introduce new compliance obligations for pharmaceutical excipient supply chains. Procurement and regulatory teams should prepare monitoring procedures to identify affected substances as soon as new candidate entries are published.

Trifluoroacetic acid has become a strategic procurement priority for GLP-1 peptide manufacturing following Solvay's European production closure. Pharmaceutical buyers should reassess sourcing strategies as Indian CDMO demand accelerates faster than supply growth.

Methanol buyers are facing a critical Q3 planning challenge as Strait of Hormuz transit remains far below normal levels. Physical shipping data now matters more than diplomatic signals when assessing supply availability and pricing risk.

India's pharmaceutical industry is rapidly expanding GLP-1 API manufacturing capacity to meet growing global demand. Securing peptide raw materials and specialty solvents will be critical for maintaining production through H2 2026.

The 2026 Hormuz shock exposed critical procurement risks, reshaping sourcing, inventory, and supplier diversification practices for chemical buyers. Learn how the crisis forced a strategic pivot and what lasting changes are required to safeguard supply chains.
Estamos comprometidos com sua privacidade. A Tradeasia usa as informações fornecidas para entrar em contato com você sobre conteúdos, produtos e serviços relevantes. Para mais informações, consulte nossa política de privacidade.